Stat Lab, founded in 1976, specializes in pre‑analytical products for laboratories and OEM customers across the U.S. and Europe. The company’s CEO, Sung‑Dae Hong, has guided its growth since inception.

Audax Private Equity and Linden Capital Partners, the current owners, have agreed to sell Stat Lab Medical Products to Leica Biosystems, an operating company of Danaher Corporation. The transaction marks a significant consolidation within the diagnostics supply chain, as Leica expands its portfolio of laboratory solutions.

The acquisition will allow Leica to deepen its footprint in the pre‑analytical segment, leveraging Stat Lab’s established distribution network in Mc Kinney, Texas, and its reputation for quality. Danaher’s broader strategy of integrating complementary technologies positions the deal as a strategic fit for both parties.

The sale underscores the growing demand for streamlined laboratory workflows and the importance of robust pre‑analytical platforms in modern diagnostics.